Zobrazeno 1 - 10
of 156
pro vyhledávání: '"Sohita, Dhillon"'
Autor:
Sohita Dhillon
Publikováno v:
Drugs. 83:275-285
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32fb6691d1e863f253d8466c17f5e5f9
https://doi.org/10.1007/s40265-023-01839-y
https://doi.org/10.1007/s40265-023-01839-y
Autor:
Sohita, Dhillon
Publikováno v:
Pediatric Drugs. 25:239-244
Sodium thiosulfate (Pedmark
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ce96769620f2809ea05243fdcf1ea0c
https://doi.org/10.1007/s40272-022-00550-x
https://doi.org/10.1007/s40272-022-00550-x
Autor:
Sohita, Dhillon
Publikováno v:
Drugs. 82:1557-1564
Pucotenlimab (Puyouheng™) is a humanised immunoglobulin (Ig) G4 monoclonal antibody (mAb) being developed by Lepu Biopharma for the treatment of solid tumours, including gastrointestinal cancer, metastatic melanoma, liver cancer, bladder cancer, no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6afa4f6f64496adba01468e740ea8180
https://doi.org/10.1007/s40265-022-01787-z
https://doi.org/10.1007/s40265-022-01787-z
Autor:
Sohita, Dhillon
Publikováno v:
Drugs. 82:1207-1212
Desidustat (Oxemia™) is an orally bioavailable, small molecule, hypoxia-inducible factor-prolyl hydroxylase (HIF-PH) inhibitor developed by Zydus Cadila for the treatment of anaemia associated with chronic kidney disease (CKD), COVID-2019 infection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f69770c6506a5211d7d00c052f0164f5
https://doi.org/10.1007/s40265-022-01744-w
https://doi.org/10.1007/s40265-022-01744-w
Autor:
Sohita, Dhillon
Publikováno v:
Drugs. 82:1011-1016
Carotegrast methyl (Carogra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6bbdb1eaeb716ba07451cf48f3dd375
https://doi.org/10.1007/s40265-022-01732-0
https://doi.org/10.1007/s40265-022-01732-0
Autor:
Sohita, Dhillon, Sean, Duggan
Publikováno v:
Drugs. 82:593-599
Sugemalimab (Cejemly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7917cca7b2a2c73895dac63189bcc41f
https://doi.org/10.1007/s40265-022-01693-4
https://doi.org/10.1007/s40265-022-01693-4
Autor:
Sohita, Dhillon
Publikováno v:
Drugs. 82:469-475
Olverembatinib (HQP1351) is an oral, third-generation BCR-ABL1 tyrosine kinase inhibitor (TKI) developed by Ascentage Pharma for the treatment of chronic myeloid leukaemia (CML), acute myeloid leukaemia, acute lymphoblastic leukaemia (ALL) and solid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01f7c5086909c05bb9484d74aa6bf41e
https://doi.org/10.1007/s40265-022-01680-9
https://doi.org/10.1007/s40265-022-01680-9
Autor:
Sohita Dhillon
Publikováno v:
Drugs. 81:2159-2166
Penpulimab (安尼可®) is a humanised anti-programmed cell death 1 (PD-1) monoclonal antibody developed by Akeso Biopharma, in collaboration with Chia Tai Tianqing (a subsidiary of SinoBiopharm), for the treatment of various cancers, including Hodg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a25dec6a2de08d91cdf8321408b0f38
https://doi.org/10.1007/s40265-021-01640-9
https://doi.org/10.1007/s40265-021-01640-9
Autor:
Sohita Dhillon
Publikováno v:
Drugs. 81:1671-1675
Telitacicept (Tai'ai®) is fusion protein comprising a recombinant transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) receptor fused to the fragment crystallizable (Fc) domain of human immunoglobulin G (IgG). Telit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4c6ad3d6017ad9e1df421df83fbf246
https://doi.org/10.1007/s40265-021-01591-1
https://doi.org/10.1007/s40265-021-01591-1